A pilot/phase II study evaluating pembrolizumab plus standard-ofcare chemotherapy in metastatic triple-negative breast cancer, with companion comprehensive immunological monitoring Meeting Abstract
| Authors: | Page, D.; Yu, W.; Conlin, A.; Ruzich, J.; Lewis, S.; Acheson, A.; Kemmer, K.; Perlewitz, K.; Moxon, N. M.; Mellinger, S.; Bifulco, C.; Martel, M.; Koguchi, Y.; Fox, B.; Urba, W.; McArthur, H. |
| Abstract Title: | A pilot/phase II study evaluating pembrolizumab plus standard-ofcare chemotherapy in metastatic triple-negative breast cancer, with companion comprehensive immunological monitoring |
| Meeting Title: | 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 4 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Nov 9-13 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2016-11-16 |
| Start Page: | 82 |
| Language: | English |
| DOI: | 10.1186/s40425-016-0172-7 |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: P152 |
Altmetric
Citation Impact
BMJ Impact Analytics
